Short Ideas

Nvidia’s (NVDA) Analyst Day Spotlights the Value of an Ecosystem, But the Stock Is Overvalued, Says Needham

Nvidia’s (NVDA) physical products are accelerators (for third-party hardware) and the company’s own GPU-powered workstations and servers. But it’s the company’s GPU-optimized software …

Should You Buy Cannabis Stock Hexo? “Heck, No!” Says Jefferies

Among marijuana investors, Hexo (HEXO) lacks the name recognition of an Aurora Cannabis, Canopy Growth, or Cronos Group — and according to Jefferies …

Deutsche Bank Still Sees Over 20% Downside for General Electric (GE) Stock; Here’s Why

Following its sale of its BioPharma business to Danaher, analysts and investors across the world are taking note of General Electric’s (GE) continued …

Intel (INTC) Stock Has Gotten off to a Good Start in 2019, But This Analyst Is Still Unconvinced

Intel (INTC) stock spiked late last week after a bullish rating came from Morgan Stanley for the first time in six years. Overall, …

Opinion: Stay Away from New Age Beverages (NBEV) Stock

New Age Beverages (NBEV) is a Colorado-based beverage company that has accumulated a portfolio of C-tier beverage brands primarily by acquiring other struggling …

This Analyst Sees Choppier Waters Ahead for Tesla (TSLA) Stock

Here we go again. That’s how some investors feel about Tesla (TSLA) after the electric car recently underwent a mass layoff and announced …

Analyst Targets Over 50% Downside for Netflix (NFLX) Stock; Here’s Why

For Netflix (NFLX), a key reason for developing its own original content is to lower its long-term costs. Just recently the company released …

Mohawk Industries (MHK) Stock Has a New Bear on Wall Street

Mohawk Industries (MHK) is like that driver motoring down the highway with the ever-blinking turn signal. Those following along behind are left wondering …

Bausch Health (BHC) Stock: Steadfast Bear Raises a New Alarm

Is Bausch Health (BHC) making a mistake in acquiring certain assets of Synergy Pharmaceuticals (SGYP)? Maybe — at least if you ask Wells Fargo’s David Maris.

Does Bausch Health (BHC) Stock Have a Clean and Bright Future? Not According to This Analyst

J.P Morgan’s Chris Schott recently met with Bausch Health (BHC) management to talk about the future of the pharmaceutical company.